|
|
Volumn 340, Issue 7737, 2010, Pages 70-
|
|
Dutch probiotics study is criticised for its "design, approval, and conduct"
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLACEBO;
PROBIOTIC AGENT;
ACUTE PANCREATITIS;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
HUMAN;
INFECTION COMPLICATION;
LEGAL ASPECT;
MEDICAL ETHICS;
METHODOLOGY;
MORTALITY;
NETHERLANDS;
NOTE;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
ACUTE DISEASE;
DOUBLE-BLIND METHOD;
HUMANS;
MULTICENTER STUDIES AS TOPIC;
NETHERLANDS;
PANCREATITIS;
PROBIOTICS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 74949139600
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.c77 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
